A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer

Ines Teles Alves; D Cano; René Böttcher; Hetty Korput; Winand Dinjens; Guido Jenster; Jan Trapman

doi:10.18632/oncotarget.13464

A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer

Ines Teles Alves
, D Cano
, René Böttcher
, Hetty Korput
, Winand Dinjens
, Guido Jenster
, Jan Trapman

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

40 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	6043-6056
Number of pages	14
Journal	Oncotarget
Volume	8
Issue number	4
DOIs	https://doi.org/10.18632/oncotarget.13464
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-49-01

Access to Document

10.18632/oncotarget.13464

REPUB_95720.pdfFinal published version, 3.41 MB

http://hdl.handle.net/1765/95720

Cite this

@article{be5b943b0c7a48c999215d180df4fcd2,

title = "A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer",

author = "\{Teles Alves\}, Ines and D Cano and Ren{\'e} B{\"o}ttcher and Hetty Korput and Winand Dinjens and Guido Jenster and Jan Trapman",

year = "2017",

doi = "10.18632/oncotarget.13464",

language = "Undefined/Unknown",

volume = "8",

pages = "6043--6056",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "4",

}

TY - JOUR

T1 - A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer

AU - Teles Alves, Ines

AU - Cano, D

AU - Böttcher, René

AU - Korput, Hetty

AU - Dinjens, Winand

AU - Jenster, Guido

AU - Trapman, Jan

PY - 2017

Y1 - 2017

U2 - 10.18632/oncotarget.13464

DO - 10.18632/oncotarget.13464

M3 - Article

C2 - 27907910

SN - 1949-2553

VL - 8

SP - 6043

EP - 6056

JO - Oncotarget

JF - Oncotarget

IS - 4

ER -